Human antibodies binding to RSV G protein
US10196438B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2014 |
| Grant date | Feb 5, 2019 |
| Priority date | — |
| Expiry date | Nov 11, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV A and B subtypes, and the use thereof in the diagnosis, prophylaxis, and/or treatment of RSV infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.